Adapting a machine learning algorithm to predict thyroid cytopathologyin LMIC

NIH RePORTER · NIH · R21 · $187,615 · view on reporter.nih.gov ↗

Abstract

Abstract Pathology expertise and services in low and middle income countries (LMIC) are severely inadequate and limited. One area in which pathology is especially critical for diagnosis and clinical decision making is thyroid related disease and cancers. The incidences of thyroid nodules and cancers have increased worldwide. A fundamental part of the clinical assessment for thyroid nodules is ultrasound-guided fine needle aspiration biopsy (FNAB). Unfortunately, this cytopathology expertise is scarce in LMIC and many nodules are surgically removed for diagnosis. Since 90-95% of these nodules are without malignancy, many patients undergo unnecessary surgery with the associated risks, financial costs, and stressing already limited resources. What is critically needed is a means to provide cytopathology expertise to interpret thyroid FNAB in LMIC. The overall goal of this proposal is to implement our ML approach into low resource settings to provide accurate and timely cytopathology analysis of FNAB specimens. This R21/33 proposal focuses on MLA adaptation using smartphones for LMIC (R21) and subsequent capacity building and implementation (R33) through well-established LMIC research partnerships in tertiary centers in Tanzania and Vietnam. We hypothesize that our MLA can use smartphone captured images to assess probability of malignancy in thyroid FNAB that is comparable to trained cytopathologists. Our Aims are: R21: Adaptation of a smartphone approach to capture cytopathology images for MLA analysis. Archived FNAB samples used at different international institutions will be used to train and adapt the MLA with these images. Furthermore, we would train local personnel in LMIC to image capture using this new setup. The results from this phase will be an adapted MLA using smartphone images that has comparable sensitivity and specificity to the original MLA. R33: Implementation of the smartphone MLA approach into LMIC clinical settings. A prospective implementation of this approach in tertiary centers in Tanzania and Vietnam will be conducted. FNAB samples obtained would undergo standard of care pathology assessment as well as be analyzed with the MLA protocol. Local cytopathologist assessment will be compared with the MLA analysis. Outcome measures include MLA assessment of slides, technical slide review and image capture, concordance with pathology between MLA and expertise both in US and LMIC. The expected outcome will lead to a cost-effective method to implement MLA for thyroid FNAB that can be used in LMIC. This approach will not only assist in early diagnosis of thyroid cancers but also improve the utilization of limited resources through effectively identifying those that need surgery from those that do not.

Key facts

NIH application ID
10458057
Project number
5R21CA268428-02
Recipient
DUKE UNIVERSITY
Principal Investigator
WALTER Tsong LEE
Activity code
R21
Funding institute
NIH
Fiscal year
2022
Award amount
$187,615
Award type
5
Project period
2021-08-01 → 2024-07-31